Trials / Completed
CompletedNCT00812864
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥ 75 Years)
Pharmacokinetic Study of Capecitabine in Elderly Cancer Patient (≥75 Years)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- University Hospital, Limoges · Academic / Other
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine blood concentration evolution of capecitabine and its active metabolites, in elderly patient 75 years and more.
Detailed description
Blood samples will be taken before 1rst course of chemotherapy of capécitabine for colorectal or breast metastatic cancer. Pharmacokinetic will be realizes at several times (H0,5, H1, H1,5, H2, H4, H6, H8) and repeated at D14 of the 2d cycle
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capecitabine | Pharmacokinetic of its metabolites. Capecitabine, 1250 mg/m2 twice a day |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-10-01
- Completion
- 2012-11-01
- First posted
- 2008-12-22
- Last updated
- 2018-08-28
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00812864. Inclusion in this directory is not an endorsement.